With more than 30 oncology partners, Gilead lays out its 2030 vision of 20 new approvals – Endpoints News

0
44
With more than 30 oncology partners, Gilead lays out its 2030 vision of 20 new approvals – Endpoints News


Last year, controversy swirled around a slate of pharma companies that paid Jeff Ricchetti — the brother of longtime Biden advisor Steve Ricchetti — to lobby legislators and the executive office of the president.

This year, it appears some companies are getting deeper into lobbying with a couple big names, according to a recent document dump from the US House of Representatives.

Well-known industry trade organization PhRMA has tapped Jeff Ricchetti for lobbying work this year, paying his company Ricchetti Incorporated $60,000 for “issues related to pharmaceutical industry, generally,” according to a quarterly report.



Source link